1.Imaging findings of mimickers of hepatocellular carcinoma.
Tae Kyoung KIM ; Eunchae LEE ; Hyun Jung JANG
Clinical and Molecular Hepatology 2015;21(4):326-343
Radiological imaging plays a crucial role in the diagnosis of hepatocellular carcinoma (HCC) as the noninvasive diagnosis of HCC in high-risk patients by typical imaging findings alone is widely adopted in major practice guidelines for HCC. While imaging techniques have markedly improved in detecting small liver lesions, they often detect incidental benign liver lesions and non-hepatocellular malignancy that can be misdiagnosed as HCC. The most common mimicker of HCC in cirrhotic liver is nontumorous arterioportal shunts that are seen as focal hypervascular liver lesions on dynamic contrast-enhanced cross-sectional imaging. Rapidly enhancing hemangiomas can be easily misdiagnosed as HCC especially on MR imaging with liver-specific contrast agent. Focal inflammatory liver lesions mimic HCC by demonstrating arterial-phase hypervascularity and subsequent washout on dynamic contrast-enhanced imaging. It is important to recognize the suggestive imaging findings for intrahepatic cholangiocarcinoma (CC) as the management of CC is largely different from that of HCC. There are other benign mimickers of HCC such as angiomyolipomas and focal nodular hyperplasia-like nodules. Recognition of their typical imaging findings can reduce false-positive HCC diagnosis.
Carcinoma, Hepatocellular/*diagnosis/radiography
;
Diagnosis, Differential
;
Hemangioma/complications/radiography/ultrasonography
;
Hepatitis B/complications
;
Humans
;
Inflammation/radiography/ultrasonography
;
Liver/radiography/ultrasonography
;
Liver Cirrhosis/complications/radiography
;
Liver Neoplasms/*diagnosis/radiography
;
Magnetic Resonance Imaging
;
Non-alcoholic Fatty Liver Disease/radiography/ultrasonography
2.Spontaneous Neoplastic Remission of Hepatocellular Carcinoma.
Sung Bae KIM ; Wonseok KANG ; Seung Hwan SHIN ; Hee Seung LEE ; Sang Hoon LEE ; Gi Hong CHOI ; Jun Yong PARK
The Korean Journal of Gastroenterology 2015;65(5):312-315
We report on a case of a 57-year-old male who underwent a curative resection for hepatocellular carcinoma (HCC) with histological confirmation of a spontaneously necrotized tumor. Initial serum AFP level was 4,778 ng/mL. A 3.7 cm hyperechoic mass in segment 6 of the liver was observed on ultrasonography and dynamic contrast-enhanced liver MRI showed a 3.7x3.1 cm sized HCC. He was scheduled to undergo curative surgical resection under the clinical diagnosis of an early stage HCC (Barcelona Clinic Liver Cancer stage A). Without treatment, the serum AFP level declined rapidly to 50 ng/mL over five weeks. He underwent curative wedge resection of segment 6 of the liver. Histology revealed complete necrosis of the mass rimmed by inflamed fibrous capsule on a background of HBV-related cirrhosis with infiltration of lymphoplasma cells. Exact pathophysiology underlying this event is unknown. Among the proposed mechanisms of spontaneous neoplastic remission of HCC, circulatory disturbance and activation of host immune response offer the most scientific explanation for the complete histologic necrosis of HCC in the resected mass seen in our patient.
Carcinoma, Hepatocellular/*diagnosis/diagnostic imaging/pathology
;
Hepatitis B/complications/diagnosis
;
Humans
;
Liver/diagnostic imaging/pathology
;
Liver Cirrhosis/etiology
;
Liver Neoplasms/*diagnosis/diagnostic imaging/pathology
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Necrosis
;
Radiography
;
Remission, Spontaneous
;
Ultrasonography
;
alpha-Fetoproteins/analysis
3.A Case of Cryptococcal Meningitis Mimicking Hepatic Encephalopathy in a Patient with Liver Cirrhosis Caused by Chronic Hepatitis C.
Hye Mi CHOI ; Gum Mo JUNG ; Woong Ki LEE ; Hyeuk Soo LEE ; Byung Sun KIM ; Choong Sil SEONG ; So Hee YOON ; Yong Keun CHO
The Korean Journal of Gastroenterology 2014;64(5):294-297
Cryptococcus neoformans, an encapsulated fungus, is an important opportunistic pathogen that can cause meningitis in immunocompromised patients. Since patients with cryptococcemia have high mortality, it is essential to make an early diagnosis and promptly initiate antifungal therapy. However, it is often very difficult to differentiate between cryptococcal meningitis and hepatic encephalopathy in patients with liver cirrhosis, and there is delay in making the diagnosis. Therefore, these patients have a particularly grave prognosis and consequently many patients die before culture results become available. In one study, starting antifungal therapy within 48 hours of the blood culture was associated with improved survival, but patients with liver cirrhosis were significantly less likely to receive antifungal therapy within 48 hours compared to those without liver cirrhosis. Recently, the authors experience a case of a 68-year-old woman with liver cirrhosis who presented with fever and a drowsy mental status. She had a previous history of having been admitted for infection-associated hepatic encephlopathy. Cryptococcal meningitis and cryptococcemia were diagnosed by spinal puncture and culture of cerebrospinal fluid. In spite of adequate treatment, the patient developed multi-system organ failure and eventually expired. Herein, we report a case of cryptococcal meningitis mimicking hepatic encephalopathy in a patient with liver cirrhosis.
Aged, 80 and over
;
Brain/radiography
;
Cryptococcus/isolation & purification
;
Female
;
Hepatic Encephalopathy/complications/*diagnosis
;
Hepatitis C, Chronic/complications/pathology
;
Humans
;
Liver Cirrhosis/etiology/pathology
;
Meningitis, Cryptococcal/complications/*diagnosis/microbiology
;
Tomography, X-Ray Computed
4.Sarcopenia as a Useful Predictor for Long-Term Mortality in Cirrhotic Patients with Ascites.
Tae Yeob KIM ; Min Yeong KIM ; Joo Hyun SOHN ; Sun Min KIM ; Jeong Ah RYU ; Sanghyeok LIM ; Youngsoo KIM
Journal of Korean Medical Science 2014;29(9):1253-1259
This study aimed to assess and compare sarcopenia with other prognostic factors for predicting long-term mortality in cirrhotic patients with ascites. Clinical data of 65 among 89 patients with measurement of all parameters were consecutively collected. Sarcopenia was evaluated as right psoas muscle thickness measurement divided by height (PMTH) (mm/m). During a mean follow-up of 20 (range: 1-49) months, 19 (29.2%) of 65 patients died. The values of the area under the receiver operating characteristics curve (AUROC) of Child-Pugh score, Model for End-Stage Liver Disease (MELD) score, MELD-Na, and PMTH for predicting 1-yr mortality were 0.777 (95% CI, 0.635-0.883), 0.769 (95% CI, 0.627-0.877), 0.800 (95% CI, 0.661-0.900), and 0.833 (95% CI, 0.699-0.924), whereas hepatic venous pressure gradient was not significant (AUROC, 0.695; 95% CI. 0.547-0.818, P=0.053). The differences between PMTH and other prognostic variables were not significant (all P>0.05). The best cut-off value of PMTH to predict long-term mortality was 14 mm/m. The mortality rates at 1-yr and 2-yr with PMTH>14 mm/m vs. PMTH< or =14 mm/m were 2.6% and 15.2% vs. 41.6% and 66.8%, respectively (P<0.001). The mortality in cirrhotic patients with PMTH< or =14 mm/m was higher than those with PMTH>14 mm/m (HR, 5.398; 95% CI, 2.111-13.800, P<0.001). In conclusion, sarcopenia, evaluated by PMTH, is an independent useful predictor for long-term mortality in cirrhotic patients with ascites.
Adult
;
Aged
;
Area Under Curve
;
*Ascites
;
Female
;
Follow-Up Studies
;
Humans
;
Liver Cirrhosis/complications/*mortality
;
Male
;
Middle Aged
;
Predictive Value of Tests
;
Prognosis
;
ROC Curve
;
Regression Analysis
;
Sarcopenia/*diagnosis/etiology/radiography
;
Severity of Illness Index
;
Survival Analysis
;
Tomography, X-Ray Computed
5.Detection of Recurrent Hepatocellular Carcinoma in Cirrhotic Liver after Transcatheter Arterial Chemoembolization: Value of Quantitative Color Mapping of the Arterial Enhancement Fraction of the Liver.
Dong Ho LEE ; Jeong Min LEE ; Ernst KLOTZ ; Soo Jin KIM ; Kyung Won KIM ; Joon Koo HAN ; Byung Ihn CHOI
Korean Journal of Radiology 2013;14(1):51-60
OBJECTIVE: To investigate the additional diagnostic value of color mapping of the hepatic arterial enhancement fraction (AEF) for detecting recurrent or residual hepatocellular carcinoma (HCC) in patients treated with transcatheter arterial chemoembolization (TACE). MATERIALS AND METHODS: Seventy-six patients with 126 HCCs, all of whom had undergone previous TACE, and subsequently, underwent follow-up multiphasic liver CT scans, were included in this study. Quantitative color maps of the AEF of the whole liver were created, by using prototype software with non-rigid registration. The AEF was defined as the ratio of the attenuation increment during the arterial phase to the attenuation increment during the portal phase. Two radiologists independently analyzed the two image sets at a two-week interval, i.e., the multiphasic CT image set and the second image set of the AEF color maps and the CT images. The additional diagnostic value of the AEF color mapping was determined, by the use of the jackknife-alternative free-response receiver-operating-characteristic analysis. The sensitivity and positive predictive values for detecting HCCs of each image set were also evaluated and compared. RESULTS: The reader-averaged figures of merit were 0.699 on the initial interpretation of the MDCT image set, and 0.831 on the second interpretation of the combined image set; the difference between the two interpretations was significant (p value < 0.001). The mean sensitivity for residual or recurrent HCC detection increased from 62.7% on the initial analysis to 82.1% on the second analysis using the AEF color maps (p value < 0.001). The mean positive predictive value for HCC detection was 74.5% on the initial analysis using MDCT, and 71.6% on the second analysis using AEF color mapping. CONCLUSION: Quantitative color mapping of the hepatic AEF may have the possibility to increase the diagnostic performance of MDCT for the detection of recurrent or residual HCC without the potential risk of radiation-related hazards.
Aged
;
Carcinoma, Hepatocellular/pathology/*radiography
;
*Chemoembolization, Therapeutic
;
Female
;
Humans
;
Liver Cirrhosis/*complications/radiography
;
Liver Neoplasms/pathology/*radiography
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local/pathology/*radiography
;
Predictive Value of Tests
;
ROC Curve
;
Radiographic Image Interpretation, Computer-Assisted
;
Retrospective Studies
;
Sensitivity and Specificity
;
Software
;
*Tomography, X-Ray Computed
6.A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease.
Clinical and Molecular Hepatology 2013;19(2):179-184
Variceal bleeding and hepatorenal syndrome (HRS) are serious and life-threatening complications of advanced liver disease. Terlipressin is widely used to manage both acute variceal bleeding and HRS due to its potency and long duration of action. The most severe (though rare) adverse event is ischemia. The present report describes the case of a patient with gangrene and osteomyelitis secondary to terlipressin therapy. A 71-year-old male with alcoholic liver cirrhosis (Child-Pugh B) and chronic hepatitis C was admitted due to a drowsy mental status. The patient had several experiences of orthopedic surgery. His creatinine level had gradually elevated to 4.02 mg/dL, and his urine output decreased to 500 mL/24 hr. The patient was diagnosed as having grade III hepatic encephalopathy (HE) and type II HRS. Terlipressin and albumin were administered intravenously to treat the HRS over 11 days. Although he recovered from the HE and HRS, the patient developed peripheral gangrene and osteomyelitis in both feet. His right toes were cured with the aid of rescue therapy, but his left three toes had to be amputated. Peripheral gangrene and osteomyelitis secondary to terlipressin therapy occur only rarely, and there is no specific rescue therapy for these conditions. Thus, attention should be paid to the possibility of ischemia of the skin and bone during or after terlipressin therapy.
Aged
;
Creatinine/blood
;
Foot/pathology
;
Gangrene/*etiology
;
Hepatitis C, Chronic/complications
;
Humans
;
Liver Cirrhosis/complications/diagnosis
;
Liver Diseases/*diagnosis/drug therapy
;
Lypressin/adverse effects/*analogs & derivatives/therapeutic use
;
Male
;
Osteomyelitis/*etiology
;
Severity of Illness Index
;
Toe Phalanges/radiography
;
Vasoconstrictor Agents/*adverse effects/therapeutic use
7.Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma.
Sang Jung PARK ; Chang Ha KIM ; Jin Dong KIM ; Soon Ho UM ; Sun Young YIM ; Min Ho SEO ; Dae In LEE ; Jun Hyuk KANG ; Bora KEUM ; Yong Sik KIM
Clinical and Molecular Hepatology 2012;18(3):316-320
Transcatheter arterial chemoembolization (TACE) has been used widely to treat patients with unresectable hepatocellular carcinoma. However, this method can induce various adverse events caused by necrosis of the tumor itself or damage to nontumor tissues. In particular, neurologic side effects such as cerebral infarction and paraplegia, although rare, may cause severe sequelae and permanent disability. Detailed information regarding the treatment process and prognosis associated with this procedure is not yet available. We experienced a case of paraplegia that occurred after conducting TACE through the intercostal artery to treat hepatocellular carcinoma that had metastasized to the rib. In this case, TACE was attempted to relieve severe bone pain, which had persisted even after palliative radiotherapy. A sudden impairment of sensory and motor functions after TACE developed in the trunk below the level of the sternum and in both lower extremities. The patient subsequently received steroid pulse therapy along with supportive care and continuous rehabilitation. At the time of discharge the patient had recovered sufficiently to enable him to walk by himself, although some paresthesia and spasticity remained.
Antiviral Agents/therapeutic use
;
Bone Neoplasms/radiography/secondary
;
Carcinoma, Hepatocellular/diagnosis/pathology/*therapy
;
Catheter Ablation
;
Chemoembolization, Therapeutic/*adverse effects
;
Hepatitis B/complications/drug therapy
;
Humans
;
Liver Cirrhosis/etiology
;
Liver Neoplasms/diagnosis/pathology/*therapy
;
Male
;
Middle Aged
;
Positron-Emission Tomography
;
Soft Tissue Neoplasms/secondary
;
Spinal Cord Injuries/*etiology
;
Tomography, X-Ray Computed
8.A Case of Hepatic Peribiliary Cysts in a Patient with Alcoholic Liver Cirrhosis.
Ji Young SEO ; Tae Hoon OH ; Tae Joo JEON ; Dong Dae SEO ; Won Chang SHIN ; Won Choong CHOI
The Korean Journal of Gastroenterology 2012;60(2):119-122
Hepatic peribiliary cysts (HPCs) are characterized by cystic dilatations of the peribiliary glands located throughout the branches of the biliary systems. Specifically, they are mainly located along the hepatic hilum and major portal tracts. The natural history and prognosis of HPCs are uncertain. In fact, almost all HPCs have been discovered incidentally during radiological examination or autopsy, and they are considered to be clinically harmless. Recently, several cases of HPCs associated with obstructive jaundice or liver failure were reported in patients with pre-existing liver disease in several studies. However, until now there have been no reports of such a case in Korea. Herein, we report a case of HPCs that show a disease course with a poor prognosis. These HPCs developed in a 47-year-old man with progressive alcoholic liver cirrhosis.
Bile Duct Diseases/complications/*diagnosis/radiography
;
Cholangiopancreatography, Magnetic Resonance
;
Cysts/*complications/radiography
;
Humans
;
Jaundice, Obstructive/etiology
;
Liver Cirrhosis, Alcoholic/complications/*diagnosis/radiography
;
Male
;
Middle Aged
;
Tomography, X-Ray Computed
9.Esophageal Sinus Formation due to Cyanoacrylate Injection for Esophageal Variceal Ligation-induced Ulcer Bleeding in a Cirrhotic Patient.
Eun Kyoung KIM ; Joo Hyun SOHN ; Tae Yeob KIM ; Bae Keun KIM ; Yeon Hwa YU ; Chang Soo EUN ; Yong Cheol JEON ; Dong Soo HAN
The Korean Journal of Gastroenterology 2011;57(3):180-183
Intravariceal injection of N-butyl-2-cyanoacrylate is widely used for the hemostasis of bleeding gastric varices, but not routinely for esophageal variceal hemorrhage because of various complications such as pyrexia, bacteremia, deep ulceration, and pulmonary embolization. We report a rare case of esophageal sinus formation after cyanoacrylate obliteration therapy for uncontrolled bleeding from post-endoscopic variceal ligation (EVL) ulcer. A 50-year-old man with alcoholic liver cirrhosis presented with hematemesis. Emergent esophagogastroscopy revealed bleeding from large esophageal varices with ruptured erosion, and bleeding was initially controlled by EVL, but rebleeding from the post-EVL ulcer occurred at 17th day later. Although we tried again EVL and the injections of 5% ethanolamine oleate at paraesophageal varices, bleeding was not controlled. Therefore, we administered 1 mL cyanoacrylate diluted with lipiodol and bleeding was controlled. Three months after the endoscopic therapy, follow-up endoscopy showed medium to large-sized esophageal varices and sinus at lower esophagus. Barium esophagography revealed an outpouching in esophageal wall and endoscopic ultrasonography demonstrated an ostium with sinus. It is noteworthy that esophageal sinus can be developed as a rare late complication of endoscopic cyanoacrylate obliteration therapy.
Cyanoacrylates/administration & dosage/*adverse effects
;
*Embolization, Therapeutic
;
Endoscopy, Digestive System
;
Esophageal and Gastric Varices/complications/*diagnosis/therapy
;
Esophagus/radiography/ultrasonography
;
Ethiodized Oil/therapeutic use
;
Gastrointestinal Hemorrhage/surgery/*therapy
;
Humans
;
Ligation
;
Liver Cirrhosis, Alcoholic/*complications/diagnosis
;
Male
;
Middle Aged
;
Tissue Adhesives/administration & dosage/*adverse effects
;
Ulcer/*complications

Result Analysis
Print
Save
E-mail